$151.3 Million
Akoya Biosciences, Inc.
Initial Public Offering
Active Bookrunner
$100.0 Million
Progenity, Inc.
Initial Public Offering
Left Bookrunner
$175.0 Million
Heska Corporation
Follow-On Offering
Active Bookrunner
$230.0 Million
Natera, Inc.
Follow-On Offering
Active Bookrunner
$40.3 Million
OncoCyte Corporation
Follow-On Offering
Left Bookrunner
$115.0 Million
Natera, Inc.
Follow-On Offering
Left Bookrunner
$56.4 Million
CareDx, Inc
Follow-On Offering
Left Bookrunner
$85.5 Million
Progenity, Inc.
Convertible Offering
Sole Underwriter
$1.0 Billion
Avantor, Inc.
Convertible Offering
Active Bookrunner
$40.6 Million
OncoCyte Corporation
Confidentially Marketed Follow-On Offering
Left Bookrunner
Subscribe to Life Sciences Tools & Diagnostics

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.